UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2023 Results Conference Call August 10, 2023 10:00 AM ET Company Participants Vincent Perrone - Head Investor Relations Liz Barrett - President and Chief Executive Officer Mark Schoenberg - Chief Medical Officer Jeff Bova - Chief Commercial Officer Don Kim - Chief Financial Officer Conference Call Participants Raghuram Selvaraju - H.C. Wainwright Boris Peaker - TD Cowen Leland Gershell - Oppenheimer Matt Kaplan - Ladenburg Thalmann Operator Good morning, ladies and gentle ...